400-1022-688
Cardiac disease diagnosis

cTnI/H-FABP Test Kit

Time-Resolved Fluorescent Immunochromagraphic Assay

          


【General Information】

1.Method: Time-resolved Fluorescent Immunochromatographic Method 

2.Bio-marker tested: cardiac troponin I (cTnI) and Heart fatty-acid binding protein (H-FABP) 

3.Clinical Sample: whole blood, serum or plasma 

4.Other Specifications: in vitro, quantitative test

 

【Clinical significance】

1. Assess infarct size and ACS risks 

2. Bio-marker for monitoring the treatment of AMI 

3.Diagnosis of acute myocardial infarction 

4.15-20 times more cardiac specific than myoglobin 

5.Diagnosis of pulmonary embolism (PE), coronary artery bypass surgery (CABG) and cerebrovascular disease

 

【Advantages】

1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography 

2. Quantitative: quantitative detection of cardiac troponin I (cTnI) and Heart fatty-acid binding protein (H-FABP) 

3. Accurate: well correlated with imported chemiluminescence reagent (r> 0.975)  

4. High sensitivity: lower detection limit <0.05 ng/mL (cTnI) and <1.0 ng/mL (H-FABP) 

5. Simple: simple operation, suitable for bedside detection 

6. Widely applicable : outpatient laboratory, emergency laboratory, medical center, cardiology, ICU, and etc 




Top

Earlier
Mar. 2014

CFDA approvals for five immunoassay reagents adaptable to most chemical analyzers were obtained

Feb. 2014

CFDA approvals for time-resolved fluorescence immunochromatographic analyzer were obtained

Sep. 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment